Ampersand Biomedicines

Ampersand Biomedicines is a biotechnology company based in Boston, Massachusetts. The company employs 28 people and has generated over $10,000 in revenue. Ampersand Biomedicines focuses on developing programmable medicines that target specific locations within the body. Their proprietary Address, Navigate, Design (AND)™ Platform utilizes computational power to identify optimal targets for these medicines, known as localizers. This platform continually learns and refines its design capabilities, resulting in increasingly sophisticated AND-Body™ therapeutics. These therapeutics are engineered to effectively target disease sites while minimizing impact on healthy tissues and cells. The company's unique approach leverages a deep understanding of both the physical properties of molecules and the biological characteristics of their targets. This allows them to create medicines that are highly precise and effective. For more information about Ampersand Biomedicines and their innovative approach to medicine, visit their website at ampersand.bio.